We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Capecitabine and Oxaliplatin Adjuvant Study in Stomach Cancer (CLASSIC)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00411229
First Posted: December 13, 2006
Last Update Posted: February 20, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Hoffmann-La Roche
Information provided by (Responsible Party):
Sanofi